P1-S4.15 Revisiting HIV epidemic appraisals for assisting in the design of effective HIV prevention programs

Swapnil Mishra(National University of Singapore), James Blanchard(University of Manitoba), Sema K. Sgaier, S Moses(Health Canada), B M Ramesh(Institute of Medical Sciences), Michel Alary(Université Laval), Lindsay C Thompson(MRC Clinical Trials Unit at UCL)

Sexually Transmitted Infections

July 1, 2011

10.1136/sextrans-2011-050108.159

Cited by 0

Related Papers

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

|Science|2021|1.5k

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

|The Lancet|2009|1.5k

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

|Nature|2021|1.4k

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

|Nature|2021|1.3k

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial

|The Lancet|2009|1.1k